Ahlskog JE - Search Results

1

Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?

Markopoulou K, Biernacka JM, Armasu SM, Anderson KJ, Ahlskog JE, Chase BA, Chung SJ, Cunningham JM, Farrer M, Frigerio R, Maraganore DM. Markopoulou K, et al. Among authors: ahlskog je. Parkinsonism Relat Disord. 2014 Jun;20(6):584-9; discussion 584. doi: 10.1016/j.parkreldis.2014.02.021. Epub 2014 Mar 5. Parkinsonism Relat Disord. 2014. PMID: 24656894 Free PMC article.

2

Movement disorders as sequelae of central pontine myelinolysis: report of three cases.

Maraganore DM, Folger WN, Swanson JW, Ahlskog JE. Maraganore DM, et al. Among authors: ahlskog je. Mov Disord. 1992;7(2):142-8. doi: 10.1002/mds.870070208. Mov Disord. 1992. PMID: 1584236 Review.

3

Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis.

Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V. Ahlskog JE, et al. Neurology. 1995 Jul;45(7):1340-4. doi: 10.1212/wnl.45.7.1340. Neurology. 1995. PMID: 7617195

4

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Collins SJ, et al. Among authors: ahlskog je. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):167-73. doi: 10.1136/jnnp.58.2.167. J Neurol Neurosurg Psychiatry. 1995. PMID: 7876846 Free PMC article.

5

Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline.

Ahlskog JE, Muenter MD, Maraganore DM, Matsumoto JY, Lieberman A, Wright KF, Wheeler K. Ahlskog JE, et al. Arch Neurol. 1994 Dec;51(12):1236-41. doi: 10.1001/archneur.1994.00540240080020. Arch Neurol. 1994. PMID: 7986180 Clinical Trial.

6

Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project.

Uitti RJ, Ahlskog JE, Maraganore DM, Muenter MD, Atkinson EJ, Cha RH, O'Brien PC. Uitti RJ, et al. Among authors: ahlskog je. Neurology. 1993 Oct;43(10):1918-26. doi: 10.1212/wnl.43.10.1918. Neurology. 1993. PMID: 8413948

7

Does levodopa therapy delay death in Parkinson's disease?

Uitti RJ, Ahlskog JE, Maraganore DM. Uitti RJ, et al. Among authors: ahlskog je. Mov Disord. 1996 May;11(3):343-4. Mov Disord. 1996. PMID: 8723162 No abstract available.

8

Intranasal apomorphine rescue therapy for parkinsonian "off" periods.

Dewey RB Jr, Maraganore DM, Ahlskog JE, Matsumoto JY. Dewey RB Jr, et al. Among authors: ahlskog je. Clin Neuropharmacol. 1996 Jun;19(3):193-201. doi: 10.1097/00002826-199619030-00001. Clin Neuropharmacol. 1996. PMID: 8726538 Clinical Trial.

9

Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone.

Kumar R, Maraganore DM, Ahlskog JE, Rodriguez M. Kumar R, et al. Among authors: ahlskog je. Neurology. 1997 Mar;48(3):732-5. doi: 10.1212/wnl.48.3.732. Neurology. 1997. PMID: 9065556

10

Guamanian neurodegenerative disease: are diabetes mellitus and altered humoral immunity clues to pathogenesis?

Ahlskog JE, Petersen RC, Waring SC, Esteban-Santillan C, Craig UK, Maraganore DM, Lennon VA, Kurland LT. Ahlskog JE, et al. Neurology. 1997 May;48(5):1356-62. doi: 10.1212/wnl.48.5.1356. Neurology. 1997. PMID: 9153473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page